The Impact of supplementation with L-carnitine in patients with heart disease undergoing cardiac surgery

Not Applicable

• Conditions: eft ventricular dysfunction, heart failure, Myocardial Ischemia; C14.280.945.900

• Registration Number: RBR-7376mq
• Lead Sponsor: niversidade Federal Fluminense

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-19
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Adults; lucid, oriented, both genders; greater than or equal to 18 years, less than or equal to 80 years, diagnosed with heart failure of ischemic etiology, NYHA functional class II and III; require coronary artery bypass grafting.

Exclusion Criteria

Renal dysfunction, hepatic dysfunction; disabsortive Syndromes; tumors, use of intra-aortic balloon; stroke, dysphagia, dialysis, sepsis, hemodynamic shock.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increasing the ejection fraction of the left ventricle determined by echocardiography at the end of the study compared to the beginning.

Secondary Outcome Measures

Name	Time	Method
Supplementation with L-carnitine in patients who present Ejection Fraction Left Ventricular lower than 50%, established by echocardiography.